SCHEMBL9918119

SCHEMBL9918119

Cc1cccc(N(c2ccccc2)c2ccc(N(c3ccc(N(c4ccccc4)c4cccc(C)c4)cc3)c3ccc(N(c4cccc(C)c4)c4cccc([Si](O)(C(C)C)C(C)C)c4)cc3)cc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
ALDH1A1 P00352 3/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
HTT P42858 2/20 0.35
JAK2 O60674 1/20 0.35
PAX8 Q06710 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
MAPT P10636 3/20 0.35
CYP1A2 P05177 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
NR1I2 O75469 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514131 0.91 ALDH1A1 (0.35) ALDH1A1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL8516060 0.88 CYP1A2 (0.35) ALDH1A1PKMCYP3A4CYP2C9CYP2C19
SCHEMBL13886460 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL22812841 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL13017732 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL10039954 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL10065627 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL13844494 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL13720602 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1
SCHEMBL10065551 0.80 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575384-B2 Silanol-containing triarylamine derivatives SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-05 US disclosed
US-8575384-B2 Silanol-containing triarylamine derivatives SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-05 US disclosed
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SIK2, AS3MT, ILK SLC6A2 1172/4885SLC6A4 1091/4885ALDH1A1 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.